Clinical Trial Update: Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating MC0518 versus best available therapy in participants with steroid-refractory acute graft-versus-host disease; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• MC0518

Snippet

Sponsor: medac GmbH | Conditions: Steroid-refractory Acute Graft-versus-host Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING